RVX-208 a selective bromodomain extra-terminal protein inhibitor reduces mace in patients with high residual risks of cardiovascular disease, a post-hoc analysis. Issue 1 (July 2015)

Record Type:: Journal Article
Title:: RVX-208 a selective bromodomain extra-terminal protein inhibitor reduces mace in patients with high residual risks of cardiovascular disease, a post-hoc analysis. Issue 1 (July 2015)
Main Title:: RVX-208 a selective bromodomain extra-terminal protein inhibitor reduces mace in patients with high residual risks of cardiovascular disease, a post-hoc analysis
Authors:: Wong, N.C.W.
Johansson, J.O.
Lebioda, K.
Halliday, C.
Kulikowski, E.
Abstract:
Is Part Of:: Atherosclerosis. Volume 241:Issue 1(2015)
Journal:: Atherosclerosis
Issue:: Volume 241:Issue 1(2015)
Issue Display:: Volume 241, Issue 1 (2015)
Year:: 2015
Volume:: 241
Issue:: 1
Issue Sort Value:: 2015-0241-0001-0000
Page Start:: e8
Page End:
Publication Date:: 2015-07
Subjects:: Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:: http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.atherosclerosis.2015.04.045 ↗
Languages:: English
ISSNs:: 0021-9150
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21838.xml